Samuel S. Lentz

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Compound C Inhibits Ovarian Cancer Progression via PI3K-AKT-mTOR-NFκB Pathway”.

Compound C Inhibits Ovarian Cancer Progression via PI3K-AKT-mTOR-NFκB Pathway

Cancers(2022)10.3390/cancers14205099

N/A

0.405DataRank · unranked

6 citations

Daniela Gonzalez, Hesham Afify, Junjun Shu, Abigail Hegarty, Jemima Adisa +5 more

The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.028

N/A

0DataRank · unranked

14 citations

Chunqiao Tian, Joshua P. Kesterson, Michael Richardson, Ken Lin, Krishnansu S. Tewari +14 more